Balance Sheet AbbVie Inc.

Stocks

ABBV

US00287Y1091

Pharmaceuticals

Market Closed - NYSE Other stock markets 04:02:28 2026-07-17 pm EDT			5-day change	1st Jan Change
254.49 ^USD	+0.04%		+2.58%	+11.38%

Jul. 17	European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus	MT
Jul. 17	AbbVie's Allergan Aesthetics Says Boey Wrinkle Treatment Wins EU Approval	MT

02a8013f664f7c57badb3a48e.2OGFZWLY-aX25AgEtaaHR6uQRjxKA8xT8XYgGv3YY_A.iKrkDlSru_-Bs11UxJG_D_qhcVEVNpNnwUBWVYuBU5Oxt7w2La3B97euPA

Published financial data: ABBVIE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	56.2B	58.05B	54.32B	56.33B	61.16B
Total Revenues	56.2B	58.05B	54.32B	56.33B	61.16B
Cost of Goods Sold, Total	17.31B	16.53B	16.73B	16.69B	17.36B
Gross Profit	38.88B	41.53B	37.59B	39.64B	43.8B
Selling General & Admin Expenses, Total	11.87B	12.08B	12.9B	13.19B	13.64B
R&D Expenses	6.98B	6.49B	7.04B	8.13B	9.07B
Other Operating Expenses	500M	-1M	-10M	-7M	-24M
Other Operating Expenses, Total	19.35B	18.57B	19.93B	21.31B	22.69B
Operating Income	19.53B	22.96B	17.66B	18.33B	21.12B
Interest Expense, Total	-2.42B	-2.23B	-2.22B	-2.81B	-2.89B
Interest And Investment Income	39M	186M	540M	648M	266M
Net Interest Expenses	-2.38B	-2.04B	-1.68B	-2.16B	-2.63B
Currency Exchange Gains (Loss)	-51M	-148M	-146M	-21M	-58M
Other Non Operating Income (Expenses)	55M	142M	190M	271M	403M
EBT, Excl. Unusual Items	17.15B	20.91B	16.02B	16.42B	18.83B
Merger & Related Restructuring Charges	-587M	-768M	-119M	-792M	-95M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	68M	172M	-	-	-
Asset Writedown	-	-876M	-4.23B	-4.48B	-847M
In Process R&D Expenses	-962M	-697M	-778M	-2.76B	-5.02B
Legal Settlements	-	-2.5B	485M	-910M	-
Other Unusual Items	-2.68B	-2.76B	-5.13B	-3.77B	-6.28B
EBT, Incl. Unusual Items	12.99B	13.48B	6.25B	3.72B	6.6B
Income Tax Expense	1.44B	1.63B	1.38B	-570M	2.36B
Earnings From Continuing Operations	11.55B	11.84B	4.87B	4.29B	4.23B
Net Income to Company	11.55B	11.84B	4.87B	4.29B	4.23B
Minority Interest	-7M	-9M	-10M	-8M	-7M
Net Income - (IS)	11.54B	11.84B	4.86B	4.28B	4.23B
Preferred Dividend and Other Adjustments	74M	54M	43M	40M	40M
Net Income to Common Incl Extra Items	11.47B	11.78B	4.82B	4.24B	4.19B
Net Income to Common Excl. Extra Items	11.47B	11.78B	4.82B	4.24B	4.19B
Per Share Items
Net EPS - Basic	6.48	6.65	2.73	2.4	2.37
Basic EPS - Continuing Operations	6.48	6.65	2.73	2.4	2.37
Basic Weighted Average Shares Outstanding	1.77B	1.77B	1.77B	1.77B	1.77B
Net EPS - Diluted	6.45	6.63	2.72	2.39	2.36
Diluted EPS - Continuing Operations	6.45	6.63	2.72	2.39	2.36
Diluted Weighted Average Shares Outstanding	1.78B	1.78B	1.77B	1.77B	1.77B
Normalized Basic EPS	6.05	7.37	5.66	5.8	6.65
Normalized Diluted EPS	6.03	7.34	5.64	5.78	6.63
Dividend Per Share	5.31	5.71	5.99	6.29	6.65
Payout Ratio	80.24	84.85	216.72	257.71	275.84
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	28.05B	31.42B	26.36B	26.72B	29.25B
EBITA	27.25B	30.65B	25.61B	25.95B	28.49B
EBIT	19.53B	22.96B	17.66B	18.33B	21.12B
EBITDAR	28.4B	31.76B	26.66B	27.06B	29.65B
Effective Tax Rate - (Ratio)	11.09	12.11	22.03	-15.34	35.83
Current Domestic Taxes	1.99B	2.65B	3.27B	-331M	1.23B
Current Foreign Taxes	351M	916M	994M	1.21B	1.63B
Total Current Taxes	2.34B	3.56B	4.27B	879M	2.86B
Deferred Domestic Taxes	-839M	-1.51B	-2.32B	-1.3B	-61M
Deferred Foreign Taxes	-59M	-419M	-565M	-146M	-431M
Total Deferred Taxes	-898M	-1.93B	-2.89B	-1.45B	-492M
Normalized Net Income	10.71B	13.06B	10B	10.26B	11.76B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	-	-	2.81B	-
Non-Cash Pension Expense	-136M	-182M	-274M	-282M	-317M
Supplemental Operating Expense Items
Advertising Expense	2.1B	2B	2.2B	2.1B	2.1B
Selling and Marketing Expenses	2.1B	2B	2.2B	2.1B	2.1B
Research And Development Expense From Footnotes	8.05B	7.21B	8.45B	15.55B	14.11B
Net Rental Expense, Total	353M	339M	305M	347M	392M
Imputed Operating Lease Interest Expense	83.09M	85.07M	86.71M	121M	133M
Imputed Operating Lease Depreciation	270M	254M	218M	226M	259M
Stock-Based Comp., COGS (Total)	46M	38M	46M	91M	52M
Stock-Based Comp., R&D Exp. (Total)	226M	232M	278M	525M	414M
Stock-Based Comp., SG&A Exp. (Total)	420M	401M	423M	805M	584M
Total Stock-Based Compensation	692M	671M	747M	1.42B	1.05B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	9.75B	9.2B	12.81B	5.52B	5.23B
Short Term Investments	84M	28M	2M	31M	28M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	9.83B	9.23B	12.82B	5.56B	5.26B
Accounts Receivable, Total	9.98B	11.25B	11.16B	10.92B	12.59B
Other Receivables	-	-	-	-	-
Total Receivables	9.98B	11.25B	11.16B	10.92B	12.59B
Inventory	3.13B	3.58B	4.1B	4.18B	4.95B
Prepaid Expenses	4.77B	4.31B	4.87B	4.76B	6.2B
Other Current Assets, Total	226M	88M	66M	165M	60M
Total Current Assets	27.93B	28.46B	33B	25.58B	29.06B
Gross Property Plant And Equipment	11.49B	11.72B	12.38B	12.99B	14.27B
Accumulated Depreciation	-5.62B	-6.05B	-6.65B	-7.13B	-7.9B
Net Property Plant And Equipment	5.87B	5.67B	5.73B	5.86B	6.36B
Long-term Investments	318M	241M	304M	279M	298M
Goodwill	32.38B	32.16B	32.29B	34.96B	35.64B
Other Intangibles, Total	75.95B	67.44B	55.61B	60.07B	52.64B
Other Long-Term Assets, Total	4.08B	4.83B	7.77B	8.42B	9.95B
Total Assets	147B	139B	135B	135B	134B
Liabilities
Accounts Payable, Total	2.88B	2.93B	3.69B	2.94B	3.59B
Accrued Expenses, Total	10.7B	12.5B	15.79B	16.82B	17.24B
Short-term Borrowings	14M	1M	-	-	2.5B
Current Portion of Long-Term Debt	12.48B	4.14B	7.18B	6.79B	6.06B
Current Portion of Leases	187M	183M	181M	195M	213M
Other Current Liabilities	8.93B	9.78B	11.01B	12B	13.68B
Total Current Liabilities	35.19B	29.54B	37.84B	38.75B	43.29B
Long-Term Debt	64.18B	59.49B	52.46B	60.55B	58.92B
Long-Term Leases	738M	771M	762M	720M	711M
Pension & Other Post Retirement Benefits	3.15B	1.64B	1.54B	1.23B	1.41B
Deferred Tax Liability Non Current	3.01B	2.19B	1.95B	2.58B	2.39B
Other Non Current Liabilities	24.82B	27.89B	29.76B	27.97B	30.47B
Total Liabilities	131B	122B	124B	132B	137B
Common Stock, Total	18M	18M	18M	18M	18M
Additional Paid In Capital	18.3B	19.24B	20.18B	21.33B	22.5B
Retained Earnings	3.13B	4.78B	-1B	-7.9B	-15.49B
Treasury Stock	-3.14B	-4.59B	-6.53B	-8.2B	-9.15B
Comprehensive Income and Other	-2.9B	-2.2B	-2.3B	-1.92B	-1.14B
Total Common Equity	15.41B	17.25B	10.36B	3.32B	-3.27B
Minority Interest	28M	33M	37M	39M	42M
Total Equity	15.44B	17.29B	10.4B	3.36B	-3.23B
Total Liabilities And Equity	147B	139B	135B	135B	134B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.77B	1.77B	1.77B	1.77B	1.77B
ECS Total Common Shares Outstanding	1.77B	1.77B	1.77B	1.77B	1.77B
Book Value / Share	8.71	9.75	5.87	1.88	-1.85
Tangible Book Value	-92.92B	-82.34B	-77.54B	-91.7B	-91.55B
Tangible Book Value Per Share	-52.55	-46.54	-43.91	-51.95	-51.79
Total Debt	77.6B	64.58B	60.58B	68.25B	68.4B
Net Debt	67.77B	55.35B	47.76B	62.7B	63.14B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.35B	116M	-295M	-1.59B	-2.55B
Debt Equivalent Oper. Leases	2.82B	2.71B	2.44B	2.78B	3.14B
Minority Interest, Total (Incl. Fin. Div)	28M	33M	37M	39M	42M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1B	1B	1.1B	1.06B	1.08B
Inventories - Work In Process, Total	1.19B	1.42B	1.64B	1.95B	2.29B
Inventories - Finished Goods, Total	932M	1.16B	1.36B	1.17B	1.58B
Land - (BS)	287M	286M	286M	284M	287M
Buildings, Total	2.79B	2.74B	2.83B	2.9B	3.06B
Machinery, Total	6.85B	7.11B	7.45B	8B	8.78B
Full Time Employees	50K	50K	50K	55K	57K
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	11.54B	11.84B	4.86B	4.28B	4.23B
Depreciation & Amortization - CF	803M	778M	752M	764M	762M
Amortization of Goodwill and Intangible Assets - (CF)	7.72B	7.69B	7.95B	7.62B	7.38B
Depreciation & Amortization, Total	8.52B	8.47B	8.7B	8.39B	8.14B
(Gain) Loss From Sale Of Asset	-68M	-172M	-	-	-
Asset Writedown & Restructuring Costs	962M	1.47B	5.01B	7.23B	5.86B
Stock-Based Compensation (CF)	692M	671M	747M	911M	955M
Other Operating Activities, Total	2.45B	2.93B	711M	780M	2.21B
Change In Accounts Receivable	-1.32B	-1.46B	66M	207M	-1.49B
Change In Inventories	-142M	-686M	-417M	-319M	-234M
Change In Accounts Payable	1.63B	1.6B	3.84B	177M	951M
Change In Deferred Taxes	-1.29B	542M	-488M	-3.21B	-762M
Change in Other Net Operating Assets	-197M	-264M	-188M	361M	-827M
Cash from Operations	22.78B	24.94B	22.84B	18.81B	19.03B
Capital Expenditure	-787M	-695M	-777M	-974M	-1.21B
Cash Acquisitions	-1.9B	-794M	-1.22B	-20.52B	-5.44B
Investment in Marketable and Equity Securities, Total	-21M	92M	-22M	482M	41M
Other Investing Activities, Total	366M	774M	13M	189M	-29M
Cash from Investing	-2.34B	-623M	-2.01B	-20.82B	-6.64B
Short Term Debt Issued, Total	-	-	-	5.01B	5.3B
Long-Term Debt Issued, Total	1B	2B	-	16.96B	3.99B
Total Debt Issued	1B	2B	-	21.97B	9.29B
Short Term Debt Repaid, Total	-	-	-	-5.01B	-2.8B
Long-Term Debt Repaid, Total	-9.41B	-14.43B	-4.15B	-9.61B	-6.8B
Total Debt Repaid	-9.41B	-14.43B	-4.15B	-14.62B	-9.6B
Issuance of Common Stock	244M	262M	180M	214M	172M
Repurchase of Common Stock	-934M	-1.49B	-1.97B	-1.71B	-980M
Common Dividends Paid	-9.26B	-10.04B	-10.54B	-11.02B	-11.66B
Common & Preferred Stock Dividends Paid	-9.26B	-10.04B	-10.54B	-11.02B	-11.66B
Other Financing Activities, Total	-674M	-1.1B	-742M	-42M	45M
Cash from Financing	-19.04B	-24.8B	-17.22B	-5.21B	-12.72B
Foreign Exchange Rate Adjustments	-97M	-62M	5M	-65M	42M
Net Change in Cash	1.3B	-545M	3.61B	-7.29B	-295M
Supplemental Items
Cash Interest Paid	2.71B	2.55B	2.47B	2.81B	3B
Cash Income Tax Paid (Refund)	3.65B	2.99B	4.7B	4.06B	3.63B
Levered Free Cash Flow	19.25B	22.97B	22.63B	19.98B	18.34B
Unlevered Free Cash Flow	20.76B	24.36B	24.02B	21.73B	20.15B
Change In Net Working Capital	-133M	-1.57B	-4.31B	-1.44B	1.03B
Net Debt Issued / Repaid	-8.41B	-12.43B	-4.15B	7.35B	-304M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.22	10.06	8.07	8.49	9.81
Return on Total Capital	12.63	16.41	14.44	16.07	19.3
Return On Equity %	80.95	72.4	35.2	62.29	6.22K
Return on Common Equity	80.52	72.14	34.91	61.94	15.22K
Margin Analysis
Gross Profit Margin %	69.19	71.53	69.21	70.37	71.62
SG&A Margin	21.13	20.82	23.76	23.41	22.31
EBITDA Margin %	49.91	54.13	48.53	47.43	47.83
EBITA Margin %	48.48	52.79	47.14	46.07	46.59
EBIT Margin %	34.75	39.54	32.51	32.54	34.52
Income From Continuing Operations Margin %	20.55	20.4	8.97	7.61	6.92
Net Income Margin %	20.54	20.39	8.95	7.59	6.91
Net Avail. For Common Margin %	20.41	20.29	8.87	7.52	6.84
Normalized Net Income Margin	19.06	22.49	18.41	18.21	19.23
Levered Free Cash Flow Margin	34.25	39.56	41.66	35.46	29.98
Unlevered Free Cash Flow Margin	36.95	41.96	44.22	38.58	32.94
Asset Turnover
Asset Turnover	0.38	0.41	0.4	0.42	0.45
Fixed Assets Turnover	9.35	10.06	9.53	9.72	10.01
Receivables Turnover (Average Receivables)	5.98	5.47	4.85	5.1	5.2
Inventory Turnover (Average Inventory)	5.38	4.93	4.36	4.03	3.8
Short Term Liquidity
Current Ratio	0.79	0.96	0.87	0.66	0.67
Quick Ratio	0.56	0.69	0.63	0.43	0.41
Operating Cash Flow to Current Liabilities	0.65	0.84	0.6	0.49	0.44
Days Sales Outstanding (Average Receivables)	61.05	66.74	75.29	71.71	70.15
Days Outstanding Inventory (Average Inventory)	67.86	74.06	83.78	90.79	96.02
Average Days Payable Outstanding	54.95	62.52	70.07	72.38	65.81
Cash Conversion Cycle (Average Days)	73.96	78.29	88.99	90.12	100.35
Long Term Solvency
Total Debt/Equity	502.7	373.59	582.66	2.03K	-2.12K
Total Debt / Total Capital	83.41	78.88	85.35	95.3	104.95
LT Debt/Equity	420.56	348.61	511.9	1.82K	-1.85K
Long-Term Debt / Total Capital	69.78	73.61	74.99	85.55	91.5
Total Liabilities / Total Assets	89.47	87.55	92.28	97.51	102.41
EBIT / Interest Expense	8.06	10.29	7.94	6.53	7.3
EBITDA / Interest Expense	11.72	14.24	11.99	9.64	10.25
(EBITDA - Capex) / Interest Expense	11.4	13.93	11.64	9.29	9.83
Total Debt / EBITDA	2.73	2.03	2.27	2.52	2.31
Net Debt / EBITDA	2.39	1.74	1.79	2.32	2.13
Total Debt / (EBITDA - Capex)	2.81	2.08	2.34	2.62	2.41
Net Debt / (EBITDA - Capex)	2.45	1.78	1.85	2.4	2.22
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	22.69	3.3	-6.44	3.71	8.57
Gross Profit, 1 Yr. Growth %	22.48	3.6	-9.48	5.46	10.49
EBITDA, 1 Yr. Growth %	26.52	6.84	-16.12	1.37	13.35
EBITA, 1 Yr. Growth %	26.71	7.12	-16.45	1.36	13.77
EBIT, 1 Yr. Growth %	24.4	9.89	-23.07	3.81	21.2
Earnings From Cont. Operations, 1 Yr. Growth %	149.87	2.56	-58.86	-12.05	-1.24
Net Income, 1 Yr. Growth %	150.04	2.55	-58.91	-12.03	-1.22
Normalized Net Income, 1 Yr. Growth %	27.41	12.93	-23.4	2.53	21.44
Diluted EPS Before Extra, 1 Yr. Growth %	137.13	2.79	-58.97	-12.13	-1.26
Accounts Receivable, 1 Yr. Growth %	13.09	12.8	-0.88	-2.12	15.29
Inventory, 1 Yr. Growth %	-5.5	14.42	14.53	2	18.42
Net Property, Plant and Equip., 1 Yr. Growth %	-4.41	-3.41	1.08	2.16	8.67
Total Assets, 1 Yr. Growth %	-2.68	-5.27	-2.95	0.33	-0.89
Tangible Book Value, 1 Yr. Growth %	-9.72	-11.39	-5.83	18.26	-0.16
Common Equity, 1 Yr. Growth %	17.83	11.98	-39.96	-67.91	-198.35
Cash From Operations, 1 Yr. Growth %	29.5	9.51	-8.44	-17.66	1.19
Capital Expenditures, 1 Yr. Growth %	-1.38	-11.69	11.8	25.35	24.64
Levered Free Cash Flow, 1 Yr. Growth %	14.17	14.25	-1.47	-11.72	-5.52
Unlevered Free Cash Flow, 1 Yr. Growth %	12.88	12.7	-1.4	-9.52	-4.81
Dividend Per Share, 1 Yr. Growth %	9.71	7.53	4.9	5.01	5.72
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	29.97	12.58	-1.69	-1.49	6.11
Gross Profit, 2 Yr. CAGR %	22.7	16.6	-1.67	-2.29	8.09
EBITDA, 2 Yr. CAGR %	31.33	21.9	-3.46	-3.51	4.26
EBITA, 2 Yr. CAGR %	31.32	22.32	-3.46	-3.58	4.36
EBIT, 2 Yr. CAGR %	17.08	25.07	-5.46	-4.8	7.67
Earnings From Cont. Operations, 2 Yr. CAGR %	21.05	60.09	-35.04	-39.85	-6.8
Net Income, 2 Yr. CAGR %	21.01	60.13	-35.09	-39.88	-6.78
Normalized Net Income, 2 Yr. CAGR %	16.14	29.65	-4.01	-4.95	6.62
Diluted EPS Before Extra, 2 Yr. CAGR %	10.53	56.12	-35.06	-39.96	-6.85
Accounts Receivable, 2 Yr. CAGR %	35.58	12.95	5.74	-1.5	6.23
Inventory, 2 Yr. CAGR %	31.35	3.98	14.47	8.08	9.9
Net Property, Plant and Equip., 2 Yr. CAGR %	33.27	-3.91	-1.19	1.62	5.37
Total Assets, 2 Yr. CAGR %	28.23	-3.98	-4.12	-1.32	-0.28
Tangible Book Value, 2 Yr. CAGR %	48	-10.56	-8.65	5.53	8.66
Common Equity, 2 Yr. CAGR %	37.31	14.87	-18	-56.1	-43.82
Cash From Operations, 2 Yr. CAGR %	30.75	19.09	0.14	-13.17	-8.72
Capital Expenditures, 2 Yr. CAGR %	19.4	-6.68	-0.64	18.38	25
Levered Free Cash Flow, 2 Yr. CAGR %	48.21	18.98	8.02	-3.06	-10.66
Unlevered Free Cash Flow, 2 Yr. CAGR %	44.98	17.13	7.18	-2.06	-9.07
Dividend Per Share, 2 Yr. CAGR %	9.98	8.62	6.21	4.96	5.37
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.72	20.4	5.85	0.08	1.75
Gross Profit, 3 Yr. CAGR %	15.81	17.15	7.16	0.65	1.79
EBITDA, 3 Yr. CAGR %	27.02	24.55	7.62	-1.88	0.65
EBITA, 3 Yr. CAGR %	27.27	24.71	7.73	-1.88	0.68
EBIT, 3 Yr. CAGR %	17.88	17.24	6.36	-2.47	1.44
Earnings From Cont. Operations, 3 Yr. CAGR %	26.64	14.54	1.78	-28.14	-29.04
Net Income, 3 Yr. CAGR %	26.61	14.51	1.75	-28.17	-29.06
Normalized Net Income, 3 Yr. CAGR %	17.03	18.03	8.79	-1.87	1.19
Diluted EPS Before Extra, 3 Yr. CAGR %	20.79	7.88	0	-28.17	-29.13
Accounts Receivable, 3 Yr. CAGR %	22.83	27.51	8.14	3.05	3.81
Inventory, 3 Yr. CAGR %	24.91	25.45	7.39	10.16	11.42
Net Property, Plant and Equip., 3 Yr. CAGR %	26.76	19.71	-2.28	-0.09	3.92
Total Assets, 3 Yr. CAGR %	35.15	15.92	-3.64	-2.66	-1.18
Tangible Book Value, 3 Yr. CAGR %	27.02	24.74	-9.01	-0.44	3.6
Common Equity, 3 Yr. CAGR %	22.19	28.29	-7.47	-40.02	-42.56
Cash From Operations, 3 Yr. CAGR %	19.26	23.25	9.1	-6.19	-8.62
Capital Expenditures, 3 Yr. CAGR %	7.25	7.98	-0.88	7.36	20.43
Levered Free Cash Flow, 3 Yr. CAGR %	15.75	37.87	11.73	0.99	-4.81
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.14	35.1	10.59	1.3	-3.84
Dividend Per Share, 3 Yr. CAGR %	10.37	9.16	7.36	5.81	5.21
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.99	15.52	10.65	11.11	5.95
Gross Profit, 5 Yr. CAGR %	14.4	14.04	8.47	8.95	7.47
EBITDA, 5 Yr. CAGR %	21.01	21.69	14	10.44	6.7
EBITA, 5 Yr. CAGR %	21.27	21.98	14.14	10.44	6.82
EBIT, 5 Yr. CAGR %	15.21	17.45	8.17	5.17	7.55
Earnings From Cont. Operations, 5 Yr. CAGR %	14.17	17.41	-3.04	-11.47	-1.74
Net Income, 5 Yr. CAGR %	14.16	17.39	-3.08	-11.5	-1.75
Normalized Net Income, 5 Yr. CAGR %	15.46	18.49	8.4	5.25	8.65
Diluted EPS Before Extra, 5 Yr. CAGR %	12.18	14.97	-5.76	-14.66	-2.8
Accounts Receivable, 5 Yr. CAGR %	15.96	17.21	15.68	15	7.37
Inventory, 5 Yr. CAGR %	16.72	17.4	20.63	18.19	8.39
Net Property, Plant and Equip., 5 Yr. CAGR %	17.66	15.14	14.74	12.12	0.71
Total Assets, 5 Yr. CAGR %	17.26	14.42	17.81	8.69	-2.31
Tangible Book Value, 5 Yr. CAGR %	18.55	16.57	11.33	16.67	-2.31
Common Equity, 5 Yr. CAGR %	27.15	27.62	4.17	-16.46	-24.21
Cash From Operations, 5 Yr. CAGR %	26.47	20.15	11.21	7.14	1.59
Capital Expenditures, 5 Yr. CAGR %	10.44	5.61	4.02	12.03	8.75
Levered Free Cash Flow, 5 Yr. CAGR %	28.36	29.87	12.76	17.92	2.48
Unlevered Free Cash Flow, 5 Yr. CAGR %	27.43	28.57	12.62	17.08	2.56
Dividend Per Share, 5 Yr. CAGR %	17.71	16.77	8.68	7.46	6.56